These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 31005679)

  • 21. Analyzing GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.
    Heifetz A; James T; Southey M; Morao I; Fedorov DG; Bodkin MJ; Townsend-Nicholson A
    Methods Mol Biol; 2020; 2114():163-175. PubMed ID: 32016893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery.
    Zhang M; Chen T; Lu X; Lan X; Chen Z; Lu S
    Signal Transduct Target Ther; 2024 Apr; 9(1):88. PubMed ID: 38594257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How Ligands Illuminate GPCR Molecular Pharmacology.
    Wacker D; Stevens RC; Roth BL
    Cell; 2017 Jul; 170(3):414-427. PubMed ID: 28753422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From purified GPCRs to drug discovery: the promise of protein-based methodologies.
    Alkhalfioui F; Magnin T; Wagner R
    Curr Opin Pharmacol; 2009 Oct; 9(5):629-35. PubMed ID: 19443270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cheminformatics in the Service of GPCR Drug Discovery.
    James T
    Methods Mol Biol; 2018; 1705():395-411. PubMed ID: 29188575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.
    Cong X; Topin J; Golebiowski J
    Curr Pharm Des; 2017 Nov; 23(29):4390-4409. PubMed ID: 28699533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design.
    Basith S; Cui M; Macalino SJY; Park J; Clavio NAB; Kang S; Choi S
    Front Pharmacol; 2018; 9():128. PubMed ID: 29593527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The application of artificial intelligence to accelerate G protein-coupled receptor drug discovery.
    Nguyen ATN; Nguyen DTN; Koh HY; Toskov J; MacLean W; Xu A; Zhang D; Webb GI; May LT; Halls ML
    Br J Pharmacol; 2024 Jul; 181(14):2371-2384. PubMed ID: 37161878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
    Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y
    Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemogenomics approaches to G-protein coupled receptor lead finding.
    Klabunde T; Jäger R
    Ernst Schering Res Found Workshop; 2006; (58):31-46. PubMed ID: 16708997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WDL-RF: predicting bioactivities of ligand molecules acting with G protein-coupled receptors by combining weighted deep learning and random forest.
    Wu J; Zhang Q; Wu W; Pang T; Hu H; Chan WKB; Ke X; Zhang Y
    Bioinformatics; 2018 Jul; 34(13):2271-2282. PubMed ID: 29432522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The identification of high-affinity G protein-coupled receptor ligands from large combinatorial libraries using multicolor quantum dot-labeled cell-based screening.
    Fu J; Lee T; Qi X
    Future Med Chem; 2014 May; 6(7):809-23. PubMed ID: 24941874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational design for thermostabilization of GPCRs.
    Popov P; Kozlovskii I; Katritch V
    Curr Opin Struct Biol; 2019 Apr; 55():25-33. PubMed ID: 30909106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New paradigms in GPCR drug discovery.
    Jacobson KA
    Biochem Pharmacol; 2015 Dec; 98(4):541-55. PubMed ID: 26265138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structures of G protein-coupled receptors reveal new opportunities for drug discovery.
    Cooke RM; Brown AJ; Marshall FH; Mason JS
    Drug Discov Today; 2015 Nov; 20(11):1355-64. PubMed ID: 26303408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From three-dimensional GPCR structure to rational ligand discovery.
    Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
    Adv Exp Med Biol; 2014; 796():129-57. PubMed ID: 24158804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GLIDA: GPCR--ligand database for chemical genomics drug discovery--database and tools update.
    Okuno Y; Tamon A; Yabuuchi H; Niijima S; Minowa Y; Tonomura K; Kunimoto R; Feng C
    Nucleic Acids Res; 2008 Jan; 36(Database issue):D907-12. PubMed ID: 17986454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
    Hoyer D; Bartfai T
    Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GPCR crystal structures: Medicinal chemistry in the pocket.
    Shonberg J; Kling RC; Gmeiner P; Löber S
    Bioorg Med Chem; 2015 Jul; 23(14):3880-906. PubMed ID: 25638496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of computational methods for class A GPCR Ligand discovery.
    Szwabowski GL; Baker DL; Parrill AL
    J Mol Graph Model; 2023 Jun; 121():108434. PubMed ID: 36841204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.